Shanghai Bank Closes $150 Million Cross-Border Acquisition Loan to Empower Strategic Integration of Medical Tech Firms

Recently, a transaction byBank of ShanghaiThe successful completion of the $150 million cross-border M&A loan not only strongly promoted the strategic integration of Enlight Medical, a domestic high-end precision medical device company, with Wallaby Medical; but also, through the synergistic model of "M&A loan + investment fund," assisted Wallaby Medical in completing significant debt restructuring and capital structure optimization, enabling it to make a crucial leap towards preparing for an overseas IPO.

This cross-border M&A loan not only demonstrates the responsibility and commitment of Bank of Shanghai, as a state-owned financial enterprise, in implementing national policies to further improve overseas comprehensive service systems and expand financing channels for Chinese enterprises going global, but also marks a strategic upgrade of Bank of Shanghai's technology financial services model from single credit allocation to an innovative ecosystem empowerment as a "financial partner."

Adhere to Long-termism, Willingly Act as "Patient Capital" to Accompany Science and Technology Enterprises Through Cycles

Wallaby Medical was founded in 2015 and is a global company focused on stroke treatment technology.Innovative HealthcareEnterprise. Shanghai Bank provided credit support to the enterprise in its early development stage, accompanying it through the layout of the European and American markets to the highlight moment of rapid expansion.

However, the road of technological innovation is full of twists and turns. Since 2023, with the changes in the external environment, Wallaby Medical has faced the squeeze of valuation correction and tightened financing in the medical device industry externally, and complex debt issues internally. Some financial institutions have chosen to reduce their exposure.

"We have chosen to 'go against the trend' and increase credit support based on our in-depth research of the neurointerventional sector and continuous tracking of the company’s core technological innovation and overseas market expansion, becoming Wallaby Medical's largest credit provider during this period of industry fluctuation," said Zhong Xiaofeng, project leader at Shanghai Bank.

Shanghai Bank deeply understands that technology companies need not only funds but also comprehensive resource support. Therefore, while helping Wallaby Medical solve the funding needs for production and operation, the bank goes beyond traditional logic and proactively collaborates with the company to explore ways to摆脱历史债务包袱and achieve healthy development. The bank continuously connects with investment institutions, corporate shareholders, and the management team to jointly plan for the arrival of "spring."

Innovative Silver-Base Synergy: Empowering Cross-Border M&A and Restructuring with Venture Capital Thinking

As the external capital market warms up and the Hong Kong stock biopharmaceutical track recovers, Shanghai Bank has keenly captured the turning point for enterprise development.

Based on long-term tracking of corporate performance and in-depth industry research, it is deeply recognized that Wallaby Medical, as one of the few companies in China with the majority of its revenue coming from high-end markets such as Europe and the US, possesses significant technological value, overseas platform value, and strategic scarcity. Shanghai Bank, together with its shareholders, devised an innovative solution of "M&A loan + investment fund."

Unlike full equity acquisitions by funds, this solution provides relatively low-cost bank leverage, which not only helps companies resolve debt crises and optimize capital structures but also, through structured M&A transaction designs, offers more operational funding for companies' global development. However, due to the acquisition target involving multiple judicial jurisdictions, dispersed shareholder governance, and an extremely complex structure, some investment funds were reserved about the feasibility of bank involvement in this M&A deal. Ultimately, Shanghai Bank delivered a swift response with its solid professional expertise.

"Having personally experienced this restructuring, I am deeply moved by the professionalism, efficiency, and human touch of Shanghai Bank. They are courageous in innovating and breaking through difficulties, and willing to offer help in times of need, supporting enterprises' growth at critical moments. I believe that Shanghai Bank's financial strength, which is full of sentiment and responsibility, will continue to empower more local enterprises to achieve steady and long-term development." Wallaby Medical CFO Jie Yu expressed her heartfelt sentiments.

Full-cycle Financial Accompaniment: Building a New Paradigm for Technology-based Financial Services

The issuance of this M&A loan is not the end of service, but a new starting point for Bank of Shanghai's full lifecycle financial companionship to enterprises. Next, Bank of Shanghai will leverage the advantages of the FT account system in efficient cross-border capital settlement and low exchange costs to assist Wallaby Medical in optimizing its global working capital management. Meanwhile, adhering to the "investment-loan linkage" mindset, the bank will continue to follow up on the company’s next round of financing and IPO process, providing comprehensive financial support.

Technological innovation is a crucial pillar of China, and financial empowerment is the key. Shanghai Bank has elevated technology finance to a strategic level, adhering to long-termism and professionalism, and is injecting strong financial momentum into fostering new productive forces and promoting a virtuous cycle of "technology-industry-finance" through financial innovation. Going forward, Shanghai Bank will replicate and promote this bank-fund collaboration model, focusing on the full lifecycle financial needs of prospective and invested enterprises, to build a “fundraising-investment-management-exit+” full-chain service ecosystem. By providing “financing + intelligence” one-stop comprehensive financial services, the bank aims to achieve strategic win-win cooperation with technology innovation enterprises and investment funds, aspiring to "become a financial partner with vision, value, abundant talent, and widespread respect" while jointly writing a new chapter in technological innovation and industrial upgrading!